Edlinger Monika, Baumgartner Susanne, Eltanaihi-Furtmüller Nadja, Hummer Martina, Fleischhacker W Wolfgang
Department of Biological Psychiatry, Innsbruck Medical University, Innsbruck, A-6020, Austria.
CNS Drugs. 2005;19(1):27-42. doi: 10.2165/00023210-200519010-00003.
The introduction of second-generation antipsychotics represents an important advance in the treatment of schizophrenia. Although these drugs are generally very effective, not all patients respond in the same way. Partial response with persistent positive and negative symptoms and residual symptoms may force physicians to change antipsychotic medication. As more and more second-generation antipsychotics are introduced, the need for practical guidelines on switching these medications becomes increasingly important. In this article we provide a short summary of the second-generation antipsychotics, focusing on efficacy, adverse effect profile and safety. Indications for switching antipsychotic medication are outlined, as well as recommendations when switching is disadvantageous. Three basic switching strategies (abrupt, gradual and overlapping switching) and their potential risks and benefits are described. We review the available evidence concerning techniques, problems and consequences when switching from one second-generation antipsychotic agent to another and discuss potential difficulties.
第二代抗精神病药物的引入是精神分裂症治疗方面的一项重要进展。尽管这些药物总体上非常有效,但并非所有患者的反应都相同。出现部分反应且持续存在阳性和阴性症状以及残留症状可能会迫使医生更换抗精神病药物。随着越来越多的第二代抗精神病药物问世,制定关于这些药物换药的实用指南的需求变得越发重要。在本文中,我们简要概述第二代抗精神病药物,重点关注疗效、不良反应谱和安全性。概述了更换抗精神病药物的适应证,以及换药不利时的建议。描述了三种基本的换药策略(突然换药、逐渐换药和重叠换药)及其潜在风险和益处。我们回顾了从一种第二代抗精神病药物换用另一种药物时有关技术、问题和后果的现有证据,并讨论了潜在困难。